Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

UltraRAD releases Ortho addition to PACS line

UltraRAD Corporation has announced that it has licensed orthopedic tools and templates packages from Cedara in a move to enter into the orthopedic market with its UltraORTHO line, the company said.

Varian adds oncology IT to its portfolio

Varian Medical Systems, Inc. used this week's American Society for Therapeutic Radiology and Oncology's annual meeting in Denver as the launching pad of its new ARIA oncology information management system.

Study: MRI a helpful tool for early breast cancer detection, treatment planning

Breast MRI is a useful tool in the detection of microscopic lesions within the breast, according to a study presented Monday at the American Society for Therapeutic Radiology and Oncology's annual meeting in Denver.

Emageon goes to Canada

Emageon Inc. has announced that it has received certificattion under the Canadian Medical Device Conformity Assessment System recognizing Emageon's ISO 13485:2003 status in Canada.

Cedara releases new native Java DICOM toolkit

Cedara Software has released the MergeCOM-3 Advanced Integrator's Native Java Tool Kit Version 3.0.

Siemens, IMPAC ink distribution extension

Siemens Medical Solutions and IMPAC Medical Systems Inc. have announced a five-year extension of their software distribution agreement.

IMV Study: Radiation oncology going digital

Radiation oncology sites in the U.S. are on the move with electronically networked system for planning treatments, but also to guide the treatment of tumors real-time, so says a recent study published by IMV Medical Information Division.

NCI, UC-San Diego develop center of excellence for cancer nanotechnology

In a new national effort to fight cancer with "nanoscale" devices that find and destroy tumor cells while leaving healthy tissue unharmed, the National Cancer Institute (NCI) awarded the University of California, San Diego $3.9 million in the first year o

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.